Could a blood extract save sight? early trial tests PRP for rare eye diseases
NCT ID NCT07341919
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This pilot study tests whether injections of platelet-rich plasma (PRP) made from a patient's own blood can help preserve vision in people with retinitis pigmentosa or a related condition called EMAP. Thirty participants receive three injections over four months, and researchers track changes in visual field and visual acuity over six months. The goal is to see if PRP is safe and might slow vision loss.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
platelet-rich plasma (PRP)
What this could lead to
If it works, this could point toward a treatment to slow vision loss in certain retinal diseases.
What could go wrong
This is a very early, small pilot study with only 30 participants. It may not show clear benefit, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA (RP) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centro Especializado Retina e Vítreo
São José do Rio Preto, São Paulo, 15010-100, Brazil